awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34666858-D197A8D1-0337-4479-B809-62FB576AE398
Q34666858-D197A8D1-0337-4479-B809-62FB576AE398
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34666858-D197A8D1-0337-4479-B809-62FB576AE398
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report.
P2860
Q34666858-D197A8D1-0337-4479-B809-62FB576AE398
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34666858-D197A8D1-0337-4479-B809-62FB576AE398
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a714a41b69524083df9e2eda71847f48230f8579
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.